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Abstract 
Inhaled nanoparticles (NPs) are experienced by the first biological barrier inside the alveolus 
known as lung surfactant (LS), a surface tension reducing agent, consisting of phospholipids 
and proteins in the form of the monolayer at the air-water interface. The monolayer surface 
tension is continuously regulated by the alveolus compression and expansion and protects the 
alveoli from collapsing. Inhaled NPs can reach deep into the lungs and interfere with the 
biophysical properties of the lung components. The interaction mechanisms of bare gold 
nanoparticles (AuNPs) with the LS monolayer and the consequences of the interactions on 
lung function are not well understood. Coarse-grained molecular dynamics simulations were 
carried out to elucidate the interactions of AuNPs with simplified LS monolayers at the 
nanoscale. It was observed that the interactions of AuNPs and LS components deform the 
monolayer structure, change the biophysical properties of LS and create pores in the 
monolayer, which all interfere with the normal lungs function.  The results also indicate that 
AuNP concentrations >0.1 mol % (of AuNPs/lipids) hinder the lowering of the LS surface 
tension, a prerequisite of the normal breathing process. Overall, these findings could help to 
identify the possible consequences of airborne NPs inhalation and their contribution to the 
potential development of various lung diseases.  
Keywords: Lung surfactant; Gold nanoparticles; Surface tension; Coarse-grained molecular 
dynamics; Lipid monolayers 
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1. Introduction 
Research on nanoparticles (NPs) in biological sectors has been driven by significant 
applications in the fields of nanomedicine, drug delivery, disease detecting and bio-sensing 
[1-4]. While NPs have the potential to advance new technologies, prior studies have also 
demonstrated their potential risk to human health. One such health risk is the uptake of 
airborne NPs [5-7], where the interaction of NPs with the lungs can alter the normal 
mechanical properties of lung components during breathing. The probability of inhaling 
airborne particles is mostly determined by the particle size, with small particles (e.g. particles 
<100 nm in diameter) more likely to be inhaled deeply into the lungs, where they may 
penetrate the epithelium and enter the bloodstream [8]. Regular inhalation of airborne NPs 
intensifies the probability of lung ageing, promoting lung malfunction, and can induce serious 
lung diseases such as asthma, lung cancer, acute respiratory distress syndrome, and more [8, 
9]. The inhaled NPs interact with the lung surfactant monolayer (LS), the first biological 
barrier inside the lung alveolus, and may cause serious damage in the surfactant layer [6, 10, 
11]. Furthermore, in experimental studies, it was found that the inhaled NPs may interact 
with the surfactant components, inhibit normal lung functioning and induce lung diseases [12, 
13].  As such, molecular level research that can explore the structural changes in the LS 
caused by the inhaled NPs, and help trace out the adverse effects of these NPs on the usual 
lungs activities, is required [14]. 
LS is mainly composed of phospholipids (saturated and unsaturated), cholesterol and a small 
number of proteins (approximately 90% lipids and 10% proteins by weight), which together 
form a stable monolayer at the air-water interface inside the alveolus [15, 16]. About half of 
the lipids consist of dipalmitoylphosphatidylcholine (DPPC) [16], a saturated phospholipid, 
which can be packed tightly in the monolayer at physiological temperature and facilitates the 
LS monolayer the ability to reach a surface tension of ~0 mN/m, without collapsing, during 
compression [17]. Other surfactant lipids, including the unsaturated phospholipid palmitoyl-
2-oleoyl-sn-glycero-3-phosphoglycerol (POPG), fluidize the monolayer and are thought to 
enhance respreading [18]. During breathing, the alveolus surface area repeatedly expands and 
compresses, LS serves to attain ~20-25 mN/m equilibrium surface tension [19] at the air-
water interface while the alveolus expands.  
Experimental [17] and computational studies [20-22] have provided information on the 
various biophysical phenomenon of LS monolayers such as phase behaviour change, surface 
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tension, surface pressure, the area per lipid (APL), LS components density, etc. An increasing 
number of studies based on molecular dynamics (MD) simulations have found that the LS 
monolayer at the air-water interface changes to the liquid condensed (LC) phase from the 
coexistence of LC and liquid expanded (LE) phases [23] as the APL decreases to ~0.46-0.47 
nm
2
 from ~0.49-0.55 nm
2 
[21]. Similarly, the surface tension of the monolayer, which is 
directly proportional to the APL [24], reaches an equilibrium value of ~23 mN/m during 
inhalation and reduces to ~0 mN/m in the LC phase upon exhalation. The major LS 
component, DPPC, undergoes a phase change from the coexistence of liquid expanded and 
condensed phases (LE+LC) to LC phase at ~41
0
C. The unsaturated lipids present in LS 
typically have a lower phase transition temperature than the saturated lipids, and so remain in 
a LE phase at a physiological temperature [25].  
Computational studies can aid in the understanding of the interaction between the surfactant 
and NPs by providing insights into the molecular level behaviour. Coarse-grained molecular 
dynamics (CGMD) simulations have been applied to explain the structural and molecular 
changes in LS due to the inhalation of different types of NPs, for example, carbon nanotubes 
[10, 11, 26], fullerene [6, 7, 27], graphene [28-30], silica [31], and others [2, 14, 32-34]. In 
addition, the interaction of LS monolayer with other molecules has been investigated, e.g. 
benzo[a]pyrene [35], antimicrobial peptides [36] and prednisolone [37] by CGMD 
simulations. The effects of NP size [2, 14, 27, 38], shape [14, 32], concentration [6, 7, 27, 37] 
and surface charge [33, 39, 40] have been considered. In LS monolayer, it was reported that 
the aggregation of larger fullerene NPs (C540) in the monolayer reduced the monolayer 
surface tension unlike the smaller fullerene NPs (C60) [27]. It was reported that small 
hydrophilic NPs (<5 nm) could quickly penetrate the LS layer [2] regardless of the NPs shape 
and LS surface tension [14]. A negligible side effect (less disruption in LS monolayer) with 
the highest penetration ability was found for the rod shape hydrophilic NPs [32] while 
hydrophobic and charged NPs could become trapped in the LS monolayer [33].  
Gold nanoparticles (AuNPs) have potential applications in bio-imaging, disease detection, 
drug delivery, and diagnostic purposes due to their biocompatibility, low-toxicity, and easy 
translocation properties [1, 3, 4]. In experimental studies, AuNPs are commonly used as a 
drug delivery agent after modifying their surfaces by the attachment biomolecule ligands [12, 
41-43]. In parallel with experimental studies, modelling studies have shown considerable 
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interest in the use of AuNPs, investigating their toxicity [44], size [38, 45], shape [46] and 
surfaces modification [47, 48].  
Excessive exposure to AuNPs may cause serious problem to human health, and the possible 
health effects of AuNPs are a continuing concern to the nanotechnology industry [49]. With 
the increased use of AuNP containing consumer products, the potential for an individual's 
exposure has also increased [50]. Goldsmiths and workers employed in gold mining and 
refining are likely to inhale gold dust [51-53], and the toxic effect of AuNPs by inhalation in 
animal models has been studied [50, 54]. Based on the emerging evidence on the toxicity of 
gold particles, the National Institute of Standards and Technology (NIST) has suggested the 
use of AuNP as a model system for nanotoxicological research [55]. Moreover, different 
experimental, medical and survey studies have shown that AuNPs can disrupt routine lungs 
functions and promote respiratory diseases [12, 13, 51, 52]. However, relatively few studies 
have investigated the interaction between human biological components and bare AuNPs [12, 
13, 56]. 
In a recent experimental study, it was postulated that the engineered NPs like AuNPs have 
potential similarities to the environmental NPs (most of the environmental NPs are treated as 
pollutants) [54]. Therefore, the findings regarding the effects of AuNPs (as pollutants) may 
be relevant to understanding the effects of other nano-pollutants on lungs. For instance, the 
observed effects of spherical and hydrophobic AuNPs on model surfactant, such as pore 
formation, lipid packing disturbance, and inhibition of some biophysical properties, may also 
be applicable to understanding effects of other spherical hydrophobic NPs [6, 7, 57]. 
The experimental paper, Bakshi et al. [12], whose work we have based our study around, 
have also reported AuNPs as model pollutants. The authors measured the surface activity of 
the surfactant membrane using a captive bubble tensiometer and reported that AuNPs lower 
the surface activity of the LS system during the breathing cycles. The authors proposed that 
bare AuNPs hinder the reduction in the surface tension value during the compression process. 
The findings of Bakshi et al. [12] are in agreement with the results of Zhang et al. [13] on the 
interaction of bare AuNPs with DPPC enriched LS monolayer. However, to the best of our 
knowledge, no computational studies on bare AuNPs interacting with LS monolayer have 
been reported to support the experimental hypothesis.  
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Recent computational studies [33, 58] have highlighted that the LS proteins adsorb quickly 
on the NP surface and mediate the protein corona formation by directly interacting with 
lipids. In this study, we only considered simplified monolayers consisting of lipids and 
cholesterol. The molecular level interactions between bare AuNPs (as model pollutants) and 
the simplified LS monolayer components were investigated using CGMD simulations. We 
used spherical hydrophobic AuNPs with a diameter of ~3 nm and concentrations of ~0.1, 
~0.9, ~1.56 and ~3.52 mol % of AuNPs/lipids. AuNP has specific properties such as 
chemical composition, nano-aggregation, the lattice constant, and potential. These properties 
provide unique attributes as compared to other hydrophobic NPs [7, 59, 60]. To our 
knowledge, there is no literature available on the modelling of bare AuNPs varying in 
concentrations with LS monolayer and this will be the first study to provide insight into 
biophysics of AuNPs interaction with LS monolayer. The simulation results will pave the 
way to rationalize how AuNPs could impede the normal pulmonary functions and could 
damage the lung alveoli by pore formation and nano-aggregation in molecular scale.  
2. Computational methods 
MD simulations were performed on a number of systems, each consisting of a water layer 
bounded by two symmetric lipid monolayers at the vacuum-water interface (Fig. 1a and Fig. 
S1a). The systems were prepared using a similar procedure as described by Baoukina et al. 
[61] and Estrada-López et al. [37]. Two different LS lipid mixtures (DPPC:POPG and 
DPPC:POPG:CHOL), separated by 6 nm of water, were used to build two different systems. 
Several experimental studies have reported that higher amounts of cholesterol (>40 mol % or 
~20 % wt/wt) greatly decrease the ability of LS to attain low surface tension, whereas 
physiological levels of cholesterol enhance the adsorption of surfactant phospholipids to the 
surface tension of ∼0 mN/m [62]. Therefore, we have considered monolayers consisting of 
10 mol % (~5% wt/wt) cholesterol in this study, consistent with physiological levels. Two 
systems with these lipid compositions were built, and single AuNP was placed close to the 
upper (vacuum) side of one monolayer only. A separate set of systems (Table 1) were 
prepared by placing the AuNPs onto both monolayers, consisting of DPPC:POPG:CHOL, 
separated by 21 nm of water. In these systems, different concentrations of AuNPs were used 
to explain the mechanism of LS monolayer perturbation by the AuNPs concentrations.  
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Fig. 1. The initial structure of model LS monolayer at the vacuum-water interface. (a) System 
configuration without AuNPs, (b) side view of the system with ~1.56 mol % of AuNPs/lipids, and (c) 
top view to the upper monolayer with ~1.56 mol % of AuNPs/lipids. 
2.1. Simplified lung surfactant model  
The bilayer systems DPPC:POPG (7:3) and DPPC:POPG:CHOL (7:3:1) were built using an 
INSANE [63] script with 1023 phospholipids in each monolayer. The two monolayers were 
prepared by separating two leaflets of a bilayer. The plane of the monolayers was parallel 
with the 𝑋𝑌 plane of the system. A water box (25 nm × 25 nm × 6 nm) was placed between 
the two monolayers and filled with ~26000 CG water beads. Then, the whole system was 
embedded in a periodic boundary box (25 nm × 25 nm × 60 nm) such that the two 
monolayers were separated by a water layer and ~50 nm of vacuum (Fig. S1a). These 
systems were extended to NP-based DPPC:POPG and DPPC:POPG:CHOL systems (Table 
S1) where a single AuNP was placed in the vacuum about 6 nm above one monolayer. In 
addition, a small control system DPPC:POPC (7:3) was prepared in accordance with the 
Estrada-López et al. studies [37] to validate all other LS systems (Table S1). The lipid order 
parameter values  of the control system were considered for comparison with Estrada-López 
et al. studies [37]. Comparison of the control system APLs and order parameters 
(supplementary information) with previously published results confirm that the choice of 
model/simulation parameters used do not introduce any artefacts. 
To study the effects of NP concentration, we also built another system consisting of the 
mixture of DPPC:POPG:CHOL (7:3:1) using the method mentioned above. Here, the two 
monolayers were separated by ~21 nm of water and ~34 nm of vacuum in a box of dimension 
25 nm × 25 nm × 60 nm, as shown in Fig. 1. Different in vivo, in vitro and in silico studies 
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have suggested that a thickness of liquid-layer ranging from 0.025 to 5 μm may have a 
significant impact on surfactant molecule transport during LS monolayer collapse [64]. A 
thinner liquid layer may slow surfactant molecule transport and thereby help to increase the 
resistance of LS to monolayer collapse [64]. We have used ~21 nm water layers as a 
compromise between computational cost and larger system size. Each monolayer contained 
1023 lipid molecules while the water slab contained about ~96,000 water beads. An ionic 
concentration of 150 mM NaCl was added to the water slab. Due to the negative charge on 
the POPG phospholipid head group, an equal number of water beads were replaced by 
positive ions (Na
+
) beads to make the systems electro-neutral.  
The DPPC:POPG:CHOL monolayer systems (Table 1) were first equilibrated (500 ns) in the 
absence of any NPs at volumes corresponding to two different APLs, 0.46 and 0.53 nm
2
, 
relating to the monolayer compression and expansion states, respectively. Once the 
monolayers had been equilibrated, the systems containing the AuNPs present were 
constructed by placing AuNPs in the vacuum space in close proximity (<1 nm) to the lipid 
tails of the monolayers. Concentrations of AuNPs of ~0.1, ~0.9, ~1.56 and ~3.52 mol % were 
simulated (here mol % was calculated as the % of molecules with respect to the total number 
of lipid and NP molecules).  
2.2. Coarse-grained molecular dynamics simulation 
All MD simulations were performed using GROMACS version 5.1.4 [65]. The MARTINI 
force field (FF) [66] was used to describe the interactions between the lipids, water and ions. 
The  CG potential parameters of Au beads were adopted from Song et al. [56] with Au beads 
assigned the MARTINI C5-type interaction site [44] (Table S2). The atomistic AuNP with a 
diameter of 3 nm was made with OpenMD [67] NP builder using a quantum-adapted variant 
of the Sutton-Chen force field [68] with a lattice constant of 0.408 nm used for gold. The 
final AuNP consisted of 887 atoms, and each atom was mapped 1:1 into CG beads (in 
contrast to the usual 4:1 mapping of MARTINI). During the simulations, the CG AuNP beads 
were connected by harmonic bonds as described elsewhere [46, 69].  
Periodic boundary conditions (PBC) were applied in all directions. A cutoff of 1.2 nm was 
used for the non-bonded interactions, with the Lennard-Jones potential shifted between 0.9 
and 1.2 nm, and the Coulomb potential shifted between 0 and 1.2 nm, such that both 
potentials were zero at the cut-off.  Before equilibration, all systems were minimized using 
the steepest descent algorithm to remove any steric clashes among lipids, water, and ions 
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molecules. In all MD simulations, the equations of motion were integrated via the leapfrog 
algorithm using a 20 fs time step. The NPγT (constant particle number, pressure and 
temperature) ensemble was applied to the systems (Table S1) with 6 nm water slab to 
investigate the LS monolayer structural, dynamical and phase transformation mechanism at 
the interface. The systems (Table 1) with 21 nm water slab were simulated in the NVT 
(constant particle number, volume and temperature) ensemble to analyse the compressed or 
extended LS monolayer properties in the presence of AuNPs. For the NVT simulations, the 
APL values were fixed at 0.46 and 0.53 nm
2
 to represent the compression and expansion 
states of the LS monolayers, respectively. The LS components (lipids with cholesterol), water 
with ions and AuNPs were coupled independently, to a velocity rescale thermostat at 310 K 
(close to the phase transition temperature of DPPC) with a relaxation time of 1 ps [70]. For 
the NPγT simulations (Table S1), Berendsen pressure barostat [71] and surface tension 
coupling were applied with compressibility 4.5 × 105 bar-1 in the 𝑋𝑌 plane and 0 bar-1 [72] 
along the Z-axis to have a constant box height. In these simulations, two different surface 
tension values 0 mN/m and 23 mN/m were used, corresponding to normal lung compression 
and expansion surface tensions, respectively [73]. All systems were equilibrated for 100 ns 
and simulated for 3 μs.  
The program Visual Molecular Dynamics (VMD) [74] was used to render the snapshots from 
all simulations. Analyses of the order parameter, density profiles, pore formation, and radial 
distribution function (RDF) were carried out over the last 1 μs of each systems. The analysis 
of AuNPs aggregation was performed over full 3 μs of simulation using the GROMACS tool 
gmx clustsize. In this cluster size analysis, a cutoff of 1.2 nm was considered for all the 
systems with multiple NPs. The same cutoff value was used in the calculation of the RDFs, 
performed using the GROMACS tool gmx rdf. The RDF calculation was performed to 
compute the density of surfactant components with respect to AuNP beads within the cutoff 
distance.  
3. Results and discussion 
3.1. Lung surfactant monolayer area per lipid and phase behaviour 
The APL of a monolayer system is used to monitor the phase transitions as well as the 
equilibration of the monolayer. The average APL of the systems simulated in the NPγT 
ensemble are given in Table S1. The results for the DPPC:POPG system indicate that the 
average value of the APL reduces to 0.470±0.001 nm2 (monolayer compression) from 
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0.572±0.001 nm2 (monolayer expansion) due to the change of surface tension to 0 mN/m 
from 23 mN/m, respectively. This change corresponds to a reduction in the surface area of 
~15%, in agreement with the results of an experimental study [12], where it is found that a 
similar level of reduction in the surface area occurred during the compression of LS 
monolayer. The surface tension has a linear relationship with the APL, and our obtained 
results follow this relationship. The relationship defines that the APL increases and decreases 
in harmony with the surface tension values during inspiration and expiration, respectively, 
replicating the expansion and compression of the alveolus surface. The presence of 
cholesterol in the monolayers results in a marked difference in the APL at both surface 
tensions (Table S1). The APL values of DPPC:POPG:CHOL drop to 0.458±0.001 nm2 and 
0.532 ±0.001 nm2 at a surface tension of 0 and 23 mN/m, respectively. The LS monolayer in 
the presence of cholesterol reduces the lateral compressibility of the LS lipids and may lead 
the LS monolayer to form a LC phase at a high concentration of cholesterol, a finding that 
was previously reported [18].  
In the initial setup of the DPPC:POPG:CHOL system with an APL of ~0.61 nm
2
, the 
monolayers exist in the LE phase (Fig. S2a). However, after equilibration at a surface tension 
~23 mN/m and physiological temperature (310 K), the DPPC:POPG:CHOL monolayers 
transfer to LE+LC phase (Fig. S2b) with a reduction of APL. A further reduction in APL 
happens under a surface tension of ~0 mN/m while the LS monolayer undergoes compression 
and the monolayer transits to the LC phase (Fig. S2c). The lipids in the LS monolayer are 
more organized and ordered in the LC phase than the other two phases (Fig. S2). From these 
results and previous simulations [75], we can conclude that the LS monolayers are in the LC 
phase at surface tension ~0 mN/m and are in the LC+LE phase at surface tension ~23 mN/m.  
We have also simulated another two systems (DPPC:POPG and DPPC:POPG:CHOL) in the 
presence of a single AuNP only in the upper monolayer to observe the effect of single AuNP 
on the biophysical function of LS. For the effect of single AuNP, we have compared the 
results from the set of systems (DPPC:POPG and DPPC:POPG:CHOL) with and without 
AuNP. We have found that the single AuNP in one monolayer has a negligible effect on the 
structural properties of the LS monolayers, as shown in Fig. S3 and Table S1 in the 
supplementary information.  
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3.2. Effect of AuNP concentration on APL and surface tension 
The effects of AuNPs concentrations on the LS monolayer at both APL are demonstrated in 
Fig. 2, for systems with AuNPs concentrations of ~0.1-3.52 mol % of AuNPs/lipids at the 
two fixed APLs of 0.53 nm
2
 (Fig. 2a-d) and 0.46 nm
2
 (Fig. 2e-h).  
Fig. 2. Snapshots taken during the course of the simulations showing the effect of AuNPs 
concentrations at APL of 0.46 nm
2
 (top view) (a-d), and at APL of 0.53 nm
2 
(side view) (e-h) on the 
LS monolayers: (a and e) presenting ~0.1 mol % of AuNPs/lipids, (b and f) presenting ~0.9 mol % of 
AuNPs/lipids, (c and g) presenting ~1.56 mol % of AuNPs/lipids, and (d, h) presenting ~3.52 mol % 
of AuNPs/lipids. The surface tensions of the monolayers consisting AuNPs with the concentrations of 
~0.1, ~0.9, ~1.56, and ~3.52 mol% of AuNPs/lipids at APLs of 0.47 nm
2
 are ~1.6, ~25.2, ~40.3, and 
~41.8 mN/m, respectively, whereas at APL of 0.53 nm
2
 are ~21.3, ~25.3, ~41.9, and ~48.1 mN/m, 
respectively. 
At both APLs, the AuNPs become embedded in the monolayers, with the phospholipid and 
cholesterol molecules binding to the surface of the NPs. The lipid-coated AuNPs disrupt the 
monolayer structure causing bulges or “pockets” to form on the monolayer.  However, these 
“pockets” of lipid-coated AuNP do not detach from the monolayer (Fig. 2) on the timescales 
simulated. The interaction of lipids with the AuNPs results in the extraction of lipids from the 
LS monolayer, which in turn leads to the creation of partial vacancies in the monolayer and 
results in the pore formation. No pores are formed in the LS monolayer at the concentrations 
 1.56 mol % of AuNPs/lipids. To the best of author’s knowledge, no captive bubble 
experiment has been performed to monitor pore formation by high concentrations of AuNPs, 
inhibiting a direct comparison of our result against experiment. However, previous MD 
simulations (e.g. [7, 57]), have reported that a high concentration of spherical NPs in the 
monolayer leads to pore formation. In our simulations, pores are observed in the monolayers, 
at both the APLs simulated, at a concentration of ~3.52 mol % of AuNPs/lipids (see Fig. 2d 
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and Fig. S4). The results suggest that the damage in LS monolayer strongly depends on the 
concentration of AuNPs and also relates to the aggregation of AuNPs, similar findings have 
been reported for other spherical hydrophobic NPs (e.g. [7, 57]).  
LS phase behaviour and APL values are regulated by the surface tension at the air-water 
interface. In the healthy human body, the surface tension value remains in the range ~20-25 
mN/m, called equilibrium surface tension, during lung alveolus expansion. During 
compression of the surface area upon exhalation, the surface tension value typically reduces ~ 
0 mN/m. To analyse the effects of AuNPs concentration on normal surface tension values, we 
have performed a series of simulations in the canonical ensemble at the two APL values 
corresponding to surface tensions of 0 and 23 mN/m for the monolayer in the absence of 
AuNPs (Table 1). In the NVT simulations, high concentrations of AuNPs interfere with 
lowering the surface tension values of LS monolayer. It is found that a very low 
concentration of AuNPs (<0.1 mol % of AuNPs/lipids) does not significantly affect the 
properties of the LS monolayer. The evidence to this claim can be the failure of pore 
formation in the LS monolayers (Fig. 2a and e), most importantly the lack of change to 
surface tension values for single AuNP in monolayers (Fig. 3), and the minor change in lipid 
order parameter (Fig. 4) values.  In the experimental view, bare AuNPs (as pollutants) at ~3.7 
mol % of AuNPs/lipids concentrations interfered with the phospholipid adsorption process to 
form LS monolayer at the equilibrium surface tension (~23 mN/m), which would disrupt 
natural lung function by inhibiting the lowering of the surface tension during compression 
process [12]. The most recent experimental studies (in vitro) also claim that at low 
concentration of AuNPs had less influence on lungs function while the higher concentrations 
greatly impeded the various lung properties [13]. In addition to the experimental findings, 
computational studies have also reported that spherical hydrophobic NPs could inhibit the LS 
ability to reduce the surface tension at higher concentration [7]. 
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Fig. 3. Effect of AuNPs concentrations on the surface tensions for systems with fixed APL values 
0.46 nm
2
, and 0.53 nm
2
. Error bars represent the error estimates using block averaging. 
In the absence of NPs, LS monolayers spontaneously attain surface tensions of ~0 and ~23 
mN/m by LS compression and expansion, respectively. The very low concentration (~0.1 mol 
% of AuNPs/lipids) of AuNPs barely affects this dynamical process (Fig. 3) of surfactant 
monolayers. Our simulation results indicate significant changes in the predicted value of the 
surface tension, resulting from the presence of AuNPs at concentrations ≥0.9 mol % 
(AuNPs/lipids), which could result in impediment of the normal function of the lungs (Fig. 
3). In summary, these results show that the lower concentration of AuNPs, ~0.1 mol %, 
barely affects normal lung function whereas higher concentrations of bare AuNPs hinder 
lowering of the surface tension values at both surface areas, which aligns with experimental 
studies [12, 13].   
3.3. Surfactant lipid order 
Lipid order parameter calculation (supplementary information) measures the structural 
ordering of the lipids within a membrane. A lowering in the value of the order parameter 
accompanies the transformation of lipid-ordered phase to the lipid-disordered phase. The 
average order parameter can vary between -0.5 and 1, with -0.5 indicating perfect anti-
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alignment of the lipid tails, and 1 indicating that the lipids tails are in perfect alignment). The 
order parameter of DPPC tail chain1 (sn-1) beads and POPC tail chain 2 (sn-2) beads at 
surface tension 0 mN/m and 20 mN/m are reported in Fig. S5, the obtained values are in 
agreement with the values published by Estrada-López et al. [37]. It has been noticed that 
saturated lipids (single bond in each chain) are more ordered, occupying less area than 
unsaturated (double bond in the chain) lipids like POPC and POPG.  
 
Fig. 4. AuNPs concentration (~0.1, ~0.9, ~1.56 and ~3.52 mol % of AuNPs/lipids) effects on DPPC 
(solid lines with triangular symbols) and POPG (dashed lines with circular symbols) lipid tails chain 
order parameters, chain 1 (sn-1) in (a, c), and chain 2 (sn-2) in (b, d) at APLs of 0.46 nm
2
 (a, b), and 
0.53 nm
2
 (c, d). The ~0.1, ~0.9, ~1.56 and ~3.52 mol % concentrations of AuNPs/lipids are shown by 
the blue, orange, green, and red lines respectively. The surface tensions of the monolayers consisting 
AuNPs with the concentrations of ~0.1, ~0.9, ~1.56, and ~3.52 mol% of AuNPs/lipids at APLs of 
0.47 nm
2
 are ~1.6, ~25.2, ~40.3, and ~41.8 mN/m, respectively, whereas at APL of 0.53 nm
2
 are 
~21.3, ~25.3, ~41.9, and ~48.1 mN/m, respectively. 
The average order parameters for the monolayers of DPPC:POPG and DPPC:POPG:CHOL 
systems are calculated at two different surface tensions in the absence (solid line) and in the 
presence (dashed line) of single AuNP in the upper layer (Fig. S3). Monolayer lipids start 
disordering at the time of the NP entering into the monolayer (Fig. S6). Visual analysis of the 
monolayers (Fig. S6a) shows that the lipids within ~1 nm of the NP are more disordered than 
those in bulk. The AuNP is partially embedded within the monolayer by 2 ns of simulation 
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time (Fig. S6b). After 16 ns, the AuNP starts to disturb the lipid tails at the vacuum interface 
and moves further towards the lipid head groups at the water interface (Fig. S6c). The 
presence of an AuNP in the monolayer induces buckling upon a lateral compression of the 
monolayer (Fig. S6b-d). This behaviour is consistent with the start of the process of 
monolayer collapse observed in previous studies. In the present study, the buckle in the 
monolayer is observed near the AuNP in one monolayer and thus failed to affect the average 
order parameter values of the lipids in both monolayers. On the other hand, significant 
differences are observed in the order parameters for the two different surface tensions (Fig. 
S3), with the lipids tail beads being more ordered at the lower surface tension. The presence 
of the double bond in the POPG sn-1 lipid chain makes it more disordered compared to 
DPPC at both surface tensions (Fig. S3). Similar to the systems with single AuNP, the 
presence of cholesterol also does not induce a significant change in lipid order parameter 
values (Fig. S3c and d). Overall, the results from simulations in the NPγT ensemble indicate 
that both DPPC and POPG lipids are more disordered at higher surface tension (Fig. S3).  
For the simulations performed in the canonical ensemble, the degree of lipid tail disordering 
in the monolayer rises along with the increase of AuNP concentration (Fig. 4). The LS 
monolayers lipids were found to be more disordered in the presence of AuNPs at both APLs 
as compared to the system in the absence of AuNPs. At the APL of 0.46 nm
2
, a sudden fall in 
order parameter values is observed in both chains beads of DPPC and POPG lipids for the 
AuNPs concentrations of ~0.1 to ~0.9 mol % and ~1.56 to ~3.52 mol % of AuNPs/lipids 
(Fig. 4a and b). Whereas, a gradual decrease in order parameter values is observed for ~0.9 to 
~1.56 mol % of AuNPs/lipids concentrations (Fig. 4a and b) at APL of 0.46 nm
2
. The 
ordering of the lipid tails is moderately decreased for all concentrations of AuNPs at the APL 
of 0.53 nm
2
, Fig. 4c and d.  
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3.4. Surfactant components density 
 
Fig. 5. AuNPs concentrations (~0.1, ~0.9, ~1.56 and ~3.52 mol % of AuNPs/lipids) effect on 
surfactant monolayer lipids, cholesterol (inset figures), and water density profiles at APLs of (a) 0.46 
nm
2
, and (b) 0.53 nm
2
. Solid line represents ~0.1 mol % of AuNPs/lipids, dash line represents ~0.9 
mol % AuNPs/lipids, dash-dotted line represents ~1.56 mol % of AuNPs/lipids, and dotted line 
represents ~3.52 mol % of AuNPs/lipids concentrations. The surface tensions of the monolayers 
consisting AuNPs with the concentrations of ~0.1, ~0.9, ~1.56, and ~3.52 mol% of AuNPs/lipids at 
APLs of 0.47 nm
2
 are ~1.6, ~25.2, ~40.3, and ~41.8 mN/m, respectively, whereas at APL of 0.53 nm
2
 
are ~21.3, ~25.3, ~41.9, and ~48.1 mN/m, respectively. 
The density profiles of the LS components have been calculated at all the concentrations of 
AuNPs (~0.1, ~0.9, ~1.56 and ~3.52 mol % of AuNPs/lipids) used in our study (Fig. 5). The 
peaks in the density profiles of the lipids at the vacuum-water interface are higher for the 
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system with an APL of 0.46 nm
2
 (Fig. 5a) than the system with an APL of 0.53 nm
2
 (Fig. 5b) 
indicating the more densely packed nature of the monolayer lipids at the lower surface area. 
The presence of AuNPs at concentrations >0.9 mol % of AuNPs/lipids significantly affect 
lipids average density profiles. The height of the peaks in the density profiles of the lipids 
drops with the increase in AuNP concentration (Fig. 5a and b). The tendency continues when 
the concentrations of AuNPs increases from ~0.9 to ~1.52 mol % and from ~1.52 to ~3.52 
mol %. Similar to the effects of AuNPs concentrations on other LS lipids, the height of the 
peaks in the cholesterol density profiles (see Figure 5 insets) decrease with the increase of 
AuNPs concentrations. 
 
 
3.5. AuNP aggregation in LS monolayer 
The aggregation of the AuNPs in LS monolayer over time was studied using a cluster size 
analysis. A cutoff of 1.2 nm is considered, meaning that two AuNPs are considered to be 
aggregated in one cluster when they were less than 1.2 nm apart from each other.  
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Fig. 6. Cluster size analysis of AuNPs (~1.56 mol % of AuNPs/lipids) at APLs of (a) 0.46 nm
2
, and 
(b) 0.53 nm
2
. Simulation time is presented along the X-axis, the number of AuNPs in the largest 
cluster is presented along the Y-axis, and the number of clusters is indicated by different colours. The 
surface tensions of the monolayers at APLs of 0.47 and 0.53 nm
2
 are ~40.3 and ~41.9 mN/m, 
respectively. 
The cluster size analyses of AuNPs at the concentrations of ≥0.9 mol % of AuNPs/lipids are 
plotted for the systems with APL of 0.46 nm
2
 (Fig. 6a, Fig. S7a and Fig. S8a) and APL of 
0.53 nm
2
 (Fig. 6b, Fig. S7b and Fig. S8b). At the beginning of the simulations, the system 
with ~1.56 mol % of AuNPs/lipids concentration contains 16 AuNPs in each monolayer, with 
all AuNPs separated by more than cutoff distance, resulting in 16 clusters (Fig. 6). As the 
simulation progresses, the AuNPs become embedded in the monolayer, where they aggregate 
as clusters of multiple AuNPs. This implies that AuNPs first interact with lipids and 
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cholesterol in the monolayer before aggregation. The AuNPs aggregation in LS monolayer is 
affected by the monolayer interfacial surface tension and the AuNP concentration (vide infra) 
[7, 27]. Also, many other factors such as chemical composition, potential, size, shape and 
hydrophobicity influence NP aggregation [60]. In our study, we have observed that once the 
AuNPs become embedded in the monolayer, they quickly become coated with lipids and then 
proceed to aggregate together. The extent to which, and how, lipids mediate this aggregation 
is a challenging question and will be the subject of future studies. However, there is some 
evidence from previous studies that a reverse micellar structure forming around NPs may 
play a role in NP aggregation [57].  
The number of clusters and the number of AuNPs in the largest cluster fluctuate over time. 
More clusters are formed at the lower APL (Fig. 6a, Fig. S7a and Fig. S8a) than the higher 
APL (Fig. 6b, Fig. S7b and Fig. S8b). Also, the chance of forming a cluster depends on the 
number of NPs in the system. It is very usual that the high concentration of AuNPs has more 
possibility of aggregating together to form clusters than the low concentration. In support of 
this claim, we have presented the cluster analysis for the concentration of ~3.52 mol % of 
AuNPs/lipids at APL of 0.46 nm
2
 (Fig. S7a) and 0.53 nm
2
 (Fig. S7b).  At this concentration, 
36 AuNPs are in each LS monolayer at the beginning of the simulations, and the distance 
between two AuNPs is less than the cutoff value. As a result, all 36 AuNPs are in a single 
cluster, and the number of NPs in the largest cluster is reduced with the increase of 
simulation time. Cluster size analysis is also performed over ~0.9 mol % of AuNPs/lipids 
system at both APL values (Fig. S8). From Figs. 6, S7 and S8, it is clear that the number of 
NPs in a cluster increases with the increase of AuNPs concentration.  At ~0.9 mol % of 
AuNPs/lipids, the largest cluster contains only 3 AuNPs (Fig. S8b) while this number has 
increased to 9 (Fig. 6b) and 24 (Fig. S7b) at the concentrations of ~1.56 mol % and ~3.52 
mol % of AuNPs/lipids, respectively at the APL of 0.53 nm
2
. At the lower surface area, the 
AuNPs aggregate more quickly. Therefore, the possibility of forming a larger size cluster has 
also increased.  
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Fig. 7. (a) AuNPs cluster formation over time at the APL of 0.46 nm
2
. The concentration was ~1.56 
mol % of AuNPs/lipids. The representative snapshots (top view) are taken at (a) 0, (b) 10, (c) 500, and 
(d) 3000 ns. The surface tension of the monolayer is ~40.3 mN/m for last 1 µs simulation. 
The process of AuNPs aggregation in the LS monolayer is illustrated in Fig. 7, where the 
formation of AuNP clusters is tracked through the simulation (0, 10, 500, and 3000 ns) for an 
exemplary system (~1.56 mol % of AuNPs/lipids at APL=0.46 nm
2
). The snapshots indicate 
the AuNPs aggregation in the surfactant monolayer started when the AuNPs absorbed in the 
monolayer (Fig. 7). In the initial setup, the 16 AuNPs are separated by about 3 nm distance 
from each other (Fig. 7a) and are placed ~1 nm above the monolayer. With increasing 
simulation time (t=10 ns) the NPs become fully submerged in the monolayer (Fig. 7b), 
wrapped by phospholipids and cholesterol molecules. As the simulation progresses (500 ns to 
3000 ns), more lipids and cholesterol adsorb to the NPs surface, and the NPs begin to 
aggregate, forming clusters of different sizes (Fig. 7c and d). 
3.6. Radial distribution function 
The RDF of each lipid and cholesterol with the beads in the AuNP are illustrated in Fig. 8a 
for both APL (0.46 and 0.56 nm
2
), at a concentration of ~0.1 mol % of AuNPs/lipids. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
20 
 
 
Fig. 8. The radial distribution function (RDF) between Au beads and lipid monolayer components at 
APLs of 0.46 nm
2
 (solid line), and 0.53 nm
2
 (dot) (b) snapshot of the interaction of AuNP (yellow) 
beads with DPPC (cyan), POPG (green) and cholesterol (red) beads within a cutoff distance 1.2 nm 
during lung compression. The surface tensions of the monolayers at APLs of 0.47 and 0.53 nm
2
 are 
~1.6 and ~21.3 mN/m, respectively. 
The distribution of lipid and cholesterol beads in the vicinity of an AuNP is shown in Fig. 8b. 
There is a clear preference for the adsorption of cholesterol to the AuNP over other two 
surfactant lipids (DPPC and POPG). This preference is probably driven by the fact that 
cholesterol is both more hydrophobic and more rigid than the other two lipids. The 
preferential binding of cholesterol to AuNPs could affect the long-range structure of LS 
monolayers by disturbing the distribution of cholesterol within the monolayers.     
4. Conclusions  
In this work, the effect of bare AuNPs on a simplified model of  a LS monolayer consisting 
of lipids and cholesterol has been studied using coarse-grained molecular dynamics 
simulation. AuNP concentrations of ~0.1-3.52 mol % have been investigated at two different 
surface areas/APL. It has been found that the AuNPs may disrupt the normal biophysical 
activity of lungs under high concentration of AuNPs, resulting in higher surface tension at the 
vacuum-water interface. The obtained results also indicate that AuNPs concentration plays a 
significant role in the order parameters of lipid tail beads. The interactions between AuNPs 
and lipids induce a decrease in order parameter values and density profiles of LS 
components. The further reduction in the order parameter and peaks in the density profiles 
are observed when the concentration of AuNPs increases. The AuNPs cluster size in LS 
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monolayer increases with AuNP concentration and decreases as the surface area of the LS 
monolayer increases. At an AuNP concentration of ~3.52 mol %, pores form in the LS 
monolayers with APLs of 0.46 and 0.53 nm
2
. Cholesterol molecules and the hydrophobic 
tails of the amphiphilic lipids interact with AuNPs, with cholesterol preferentially adsorbing 
to the surface of the AuNP over the phospholipid tails. The consequence of this disruption of 
the LS monolayer is that the normal functions of the lungs are affected. More specifically, 
AuNPs hinder the ability of the LS monolayer to achieve normal surface tension during 
breathing. Overall, the study provides molecular insights of model AuNPs (as pollutants) 
with model LS monolayer at the vacuum-water interface. The findings of this study bring to 
light the possible consequences of AuNP inhalation and the possible causes of those effects. 
The results of this study provide clear and understandable molecular insights that could be 
helpful to design future nanomedicine along with the assessment of AuNP as a pollutant.  
Also, the results of our model simulations will assist in understanding different lung diseases 
due to the inhalation of environmental NPs in different concentration levels. Furthermore, the 
study will help to identify the potential health risk in people dealing with bare AuNP as an 
engineered nanoparticle in the laboratory or gold mines.  
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 LIST OF TABLE 
Table 1. Summary of the simulation systems with 651 DPPC, 279 POPG and 93 cholesterol 
molecules per monolayer. The water thickness was 21 nm between two monolayers, and the 
temperature was at 310 K. 
AuNP concentrations 
(mol %) 
No. of AuNPs 
in each monolayer 
APL 
nm
2
 
Pore 
formation 
~0.1 1 0.46 No 
0.53 No 
~0.9 9 0.46 No 
0.53 No 
~1.56 16 0.46 No 
0.53 No 
~3.52 36 0.46 Yes 
0.53 Yes 
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Highlights 
 AuNPs pollutants affect the structural and dynamical properties of the lung surfactant 
monolayer in molecular dynamics simulations. 
 AuNPs inhibit to lower the surface tension values of surfactant monolayer during the 
breathing process. 
 A high concentration of AuNPs in the surfactant monolayer induces pore formation. 
 Upon entering the LS monolayer lipids adsorb to the surface of the AuNPs, before the 
AuNPs aggregate into clusters. 
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